Test ID FBBAB Lyme Disease Antibody Index for CNS Infection
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
FZ003 | Lyme Disease Ab Index | No | Yes |
FZ004 | Albumin Ratio | No | No |
Method Name
Enzyme Linked Immunosorbent Assay (ELISA) and Nephelometry (NEPH)
Reporting Name
Lyme Disease Ab for CNS InfectionSpecimen Type
CSFSerum
Requires Serum AND CSF
Draw blood in a red-top tube(s) (Serum gel tube is acceptable.) Spin down and submit 2 mL refrigerate serum.
Collect 2 mL CSF in a sterile plastic vial and submit refrigerate.
Note: Serum and CSF must be drawn within 24 hours of each other.
Specimen Minimum Volume
1 mL serum AND 1 mL CSF
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
CSF | Refrigerated (preferred) | 14 days |
Frozen | 30 days | |
Ambient | 7 days | |
Serum | Refrigerated (preferred) | 14 days |
Frozen | 30 days | |
Ambient | 7 days |
Reference Values
Lyme Disease Antibody Index:
≤ 1.0 Negative
1.1 - 1.2 Equivocal
≥ 1.3 Positive
Control Antibody Index: ≤ 1.0
Albumin Ratio: <0.0078
The Lyme Disease Antibody Index is used as an aid for the diagnosis of neuroborreliosis. An increased Lyme Disease Antibody Index (>1.2), accompanied by a Control Antibody Index of less than 1.0 and an Albumin Ratio of less than 0.0078, is strong evidence for intrathecal synthesis of organism-specific antibody, and thus CNS B. burgdorferi infection. Elevation of either the control antibody index, the Albumin Ratio, or both may indicate leakage of antibody across the blood-brain barrier which may falsely elevate the Lyme Disease Antibody Index.
Day(s) Performed
Tuesday and Friday
Report Available
1 weekPerforming Laboratory
Focus Diagnositics, Inc.CPT Code Information
82040
82042
82784/x2
86618/x4